Compound Detail
CHEMBL13
METOPROLOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL13 |
| Name | METOPROLOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | IUBSYMUCCVWXPE-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
11
Targets
37
Activities
3
Assay Types
30
PK Parameters
20
Publications
9
Known Names
20
Indications
Molecular Properties
267.4
MW (Da)
1.61
ALogP
4
HBA
2
HBD
50.7
PSA (Ų)
0.71
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1978 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Cardiovascular Diseases Atherosclerosis Atrial Fibrillation Breast Neoplasms Coronary Disease Diabetes Mellitus, Type 2 Heart Failure Heart Failure Hypercholesterolemia Hypertension Myocardial Infarction Myocardial Infarction Non-ST Elevated Myocardial Infarction Respiratory Distress Syndrome ST Elevation Myocardial Infarction Arrhythmias, Cardiac beta-Thalassemia Death, Sudden, Cardiac Heart Arrest Heart Diseases
ATC Classification
C07AB02
metoprolol
Level 1: CARDIOVASCULAR SYSTEM
Level 2: BETA BLOCKING AGENTS
Activity Summary
Ki 14 meas. best 7.35
Kd 13 meas. best 7.83
IC50 10 meas. best 6.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Beta-1 adrenergic receptor CHEMBL5471 | Kd | 7.83 | 7.4075 | 14.8 | 4 |
| Beta-1 adrenergic receptor CHEMBL213 | Kd | 7.8 | 7.8 | 15.8 | 1 |
| Beta-1 adrenergic receptor CHEMBL3252 | Kd | 7.64 | 7.64 | 22.9 | 3 |
| Unchecked CHEMBL612545 | Ki | 7.35 | 7.35 | 45.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL3440 | Ki | 7.31 | 7.31 | 49.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL213 | Ki | 7.26 | 7.125 | 55.0 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | Kd | 6.89 | 5.85 | 130.0 | 2 |
| Beta-2 adrenergic receptor CHEMBL5414 | Kd | 6.79 | 6.79 | 162.2 | 3 |
| Beta-1 adrenergic receptor CHEMBL213 | IC50 | 6.75 | 6.75 | 176.0 | 1 |
| Beta-1 adrenergic receptor CHEMBL5471 | IC50 | 6.72 | 6.61 | 190.0 | 2 |
| Beta-2 adrenergic receptor CHEMBL210 | Ki | 6.66 | 6.205 | 220.0 | 2 |
| Beta-1 adrenergic receptor CHEMBL3252 | Ki | 6.4 | 5.82 | 398.1 | 5 |
| Adrenergic receptor beta CHEMBL2095166 | IC50 | 6.3 | 6.3 | 500.0 | 1 |
| Beta-2 adrenergic receptor CHEMBL210 | IC50 | 5.59 | 5.59 | 2573.0 | 1 |
| Cytochrome P450 2J2 CHEMBL3491 | IC50 | 5.31 | 5.31 | 4870.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | Ki | 5.0 | 5.0 | 10000.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 4.62 | 4.62 | 24000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 12.15 | mL.min-1.kg-1 | Homo sapiens |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 12.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 185.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 15.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 23.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 30.0 | mL.min-1.kg-1 | Macaca |
| CL | 46.5 | mL.min-1.kg-1 | Homo sapiens |
| CL | 13.0 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 8.41 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 13.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.8 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 1.13 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 13.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 33.0 | mL.min-1.kg-1 | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| F | 38.0 | % | Homo sapiens |
| F | 95.0 | % | Homo sapiens |
| F | 102.0 | % | Homo sapiens |
| Fu | 0.89 | - | - |
| Fu | 0.084 | - | - |
| Fu | 0.89 | - | Homo sapiens |
| Fu | 0.88 | - | Homo sapiens |
| Fu | 0.88 | - | Homo sapiens |
| Fu | 0.9 | - | Rattus norvegicus |
| Fu | 1.0 | - | Homo sapiens |
| Fu | 0.46 | - | Rattus norvegicus |
| Fu | 0.8 | - | Not specified |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 746 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 62 |
| - | 10.6019/CHEMBL4295262 | Unchecked | 44 |
| 16472241 | 10.2174/1570163043334794 | Hepatotoxicity | 18 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 21245286 | 10.1124/dmd.110.036806 | Liver | 12 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 15920768 | 10.1002/jps.20373 | ADMET | 8 |
| 15658873 | 10.1021/jm049711o | ADMET | 5 |
| 33550184 | 10.1016/j.ejmech.2021.113232 | ADMET | 5 |
| 12061889 | 10.1021/jm0200409 | ADMET | 5 |
| 32480301 | 10.1016/j.ejmech.2020.112465 | ADMET | 5 |
| 17418579 | 10.1016/j.bmc.2007.03.040 | ADMET | 5 |
| 25799158 | 10.1021/acs.jmedchem.5b00201 | Homo sapiens | 5 |
| 16759089 | 10.1021/jm050624l | Beta-1 adrenergic receptor | 5 |
| 19397318 | 10.1021/jm9003945 | No relevant target | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
Data from ChEMBL 36 via Core Engine